Portfolio company Hy2Care was selected for the MedTech Innovator 2026 Accelerator Cohort.
Hy2Care® is a spin-off company from the Tech Med Centre of the University of Twente, focused on developing hydrogel technology for cartilage repair
Hy2Care® is a spin-off company from the Tech Med Centre of the University of Twente, focused on developing hydrogel technology for cartilage repair. Their flagship product, the CartRevive® hydrogel implant, aims to facilitate the natural regeneration of cartilage tissue in patients with traumatic focal defects.